(Q48274036)

10 February 2018

title

The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. (English)

1 reference

10 February 2018

1 reference

Kelly H Skelton

1

1 reference

10 February 2018

David A Gutman

2

1 reference

10 February 2018

K V Thrivikraman

3

1 reference

10 February 2018

Charles B Nemeroff

4

1 reference

10 February 2018

Michael J Owens

5

1 reference

10 February 2018

publication date

13 February 2007

1 reference

10 February 2018

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 February 2018

volume

192

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

385-396

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-007-0713-3

exact match

0 references

cites work

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

12 December 2020

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

1 reference

12 December 2020

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

1 reference

12 December 2020

Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN)

1 reference

12 December 2020

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

1 reference

12 December 2020

Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

1 reference

12 December 2020

Physiology and pharmacology of corticotropin-releasing factor

1 reference

12 December 2020

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety

1 reference

12 December 2020

Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala

1 reference

12 December 2020

Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

1 reference

12 December 2020

Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine

1 reference

12 December 2020

Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

1 reference

12 December 2020

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

1 reference

12 December 2020

Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.

1 reference

12 December 2020

The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal

1 reference

12 December 2020

Effect of chlordiazepoxide on stress in rats

1 reference

12 December 2020

Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function

1 reference

12 December 2020

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats

1 reference

12 December 2020

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

12 December 2020

Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.

1 reference

12 December 2020

ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats

1 reference

12 December 2020

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

1 reference

12 December 2020

Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment

1 reference

12 December 2020

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

1 reference

12 December 2020

Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system

1 reference

12 December 2020

In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications

1 reference

12 December 2020

Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal

1 reference

12 December 2020

Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder

1 reference

12 December 2020

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

1 reference

12 December 2020

Experimental induction of benzodiazepine tolerance and physical dependence

1 reference

12 December 2020

Corticotropin-releasing factor has an anxiogenic action in the social interaction test.

1 reference

12 December 2020

Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.

1 reference

12 December 2020

Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

1 reference

12 December 2020

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

1 reference

12 December 2020

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

1 reference

12 December 2020

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence

1 reference

12 December 2020

Long-term pharmacologic treatment of panic disorder

1 reference

12 December 2020

Ethanol dependence and the pituitary adrenal axis in mice. II. Temporal analysis of dependence and withdrawal.

1 reference

12 December 2020

The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam.

1 reference

12 December 2020

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

12 December 2020

Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus

1 reference

12 December 2020

Characteristics of long-term alprazolam users in the community

1 reference

12 December 2020

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

12 December 2020

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

12 December 2020

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

12 December 2020

Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis is dependent upon stressor specific neurocircuitry

1 reference

12 December 2020

Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.

1 reference

12 December 2020

Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal

1 reference

12 December 2020

Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat.

1 reference

12 December 2020

Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity

1 reference

12 December 2020

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

1 reference

12 December 2020

Combined pre- and postnatal environmental enrichment programs the HPA axis differentially in male and female rats

1 reference

12 December 2020

10.1007/S00213-007-0713-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018